Table 1 Baseline characteristics in the intention-to-treat population (N = 16; all hospitalized and on invasive ventilation).
N | Mean (±SD) | Median or freq. | Range or percentage | |
|---|---|---|---|---|
Age (yrs.) | 16 | 59.5 (±14.92) | 59 | 35–92 |
Sex, female/male (Pts./%) | 16 | 3/13 | 18.75/81.25% | |
Weight (kg) | 16 | 89.25 (±17.76) | 90 | 60–127 |
Height (cm) | 16 | 175.2 (±6.06) | 175 | 163–186 |
BMI (kg/m2) | 16 | 29.2 (±6.65) | 28 | 22–47.8 |
Vital signs | ||||
Heart rate (beats per minute) | 16 | 77.1 (±17.1) | 74.0 | 55–120 |
Respiratory rate (breaths per minute) | 16 | 16.8 (±5) | 14.5 | 12–28 |
PaO2/FiO2 (ratio) | 16 | 167.3 (±148.7) | 147.5 | 55–680 |
Blood Pressure, systolic (mmHg) | 16 | 109.8 (±13.2) | 110.0 | 90–135 |
Blood Pressure, diastolic (mmHg) | 16 | 55.4 (±10.7) | 55.0 | 40–80 |
Temperature (°C) | 16 | 36.8 (±1.3) | 36 | 35–39.6 |
Risk factors | ||||
N Pts. | N Risk Factors | |||
Chronic liver disease | 2 | 2 | ||
Chronic lung disease | 2 | 2 | ||
Chronic nervous system disorder | 3 | 3 | ||
DNR status | 1 | 1 | ||
Diabetes | 4 | 4 | ||
Disorder of cardiovascular system | 10 | 20 | ||
Malignant neoplastic disease | 2 | 2 | ||
Respiratory therapy (before trial) | 12 | 12 | ||
Rheumatological/Immunological disease | 4 | 7 | ||
Smoking status (smoker/former smoker) | 6 | 6 | ||
Thromboembolic event | 3 | 3 | ||
